V0251 oral suspension efficacy and tolerance in vestibular neuritis. A randomised double-blind placebo controlled study
V0251 oral suspension efficacy and tolerance in vestibular neuritis. A randomised double-blind placebo controlled study
V0251 oral suspension efficacy and tolerance in vestibular neuritis. A randomised double-blind placebo controlled study
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
80
Years old
Gender
All
Therapeutic area :
Central Nervous System
Disease :
Acute vestibular neuritis
Study medication :
Phase :
Phase II
Start Date :
May 17, 2011
End date :
April 30, 2012
Study ID :
V00251 ST 201 1A
EudraCT/CTIS number :
2010-023099-13
Send by email